PL3644982T3 - Związki 3-hydroksymaślanu do zastosowania w redukowaniu tłuszczu wątrobowego - Google Patents

Związki 3-hydroksymaślanu do zastosowania w redukowaniu tłuszczu wątrobowego

Info

Publication number
PL3644982T3
PL3644982T3 PL18737388.1T PL18737388T PL3644982T3 PL 3644982 T3 PL3644982 T3 PL 3644982T3 PL 18737388 T PL18737388 T PL 18737388T PL 3644982 T3 PL3644982 T3 PL 3644982T3
Authority
PL
Poland
Prior art keywords
liver fat
reducing liver
hydroxybutyrate compounds
hydroxybutyrate
compounds
Prior art date
Application number
PL18737388.1T
Other languages
English (en)
Polish (pl)
Inventor
Kieran Clarke
Original Assignee
Tdeltas Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tdeltas Limited filed Critical Tdeltas Limited
Publication of PL3644982T3 publication Critical patent/PL3644982T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
PL18737388.1T 2017-06-27 2018-06-22 Związki 3-hydroksymaślanu do zastosowania w redukowaniu tłuszczu wątrobowego PL3644982T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1710229.4A GB201710229D0 (en) 2017-06-27 2017-06-27 Compounds for new use
PCT/GB2018/051752 WO2019002828A1 (en) 2017-06-27 2018-06-22 3-HYDROXYBUTYRATE COMPOUNDS FOR USE IN THE REDUCTION OF HEPATIC FAT

Publications (1)

Publication Number Publication Date
PL3644982T3 true PL3644982T3 (pl) 2023-08-14

Family

ID=59523693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18737388.1T PL3644982T3 (pl) 2017-06-27 2018-06-22 Związki 3-hydroksymaślanu do zastosowania w redukowaniu tłuszczu wątrobowego

Country Status (13)

Country Link
US (2) US12439944B2 (https=)
EP (2) EP4215189A1 (https=)
JP (2) JP7374000B2 (https=)
KR (1) KR102680437B1 (https=)
CN (1) CN110869012B (https=)
AU (1) AU2018293398B2 (https=)
CA (1) CA3066948A1 (https=)
DK (1) DK3644982T3 (https=)
ES (1) ES2945964T3 (https=)
GB (2) GB201710229D0 (https=)
PL (1) PL3644982T3 (https=)
TW (1) TWI811222B (https=)
WO (1) WO2019002828A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710229D0 (en) * 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
GB2577723A (en) 2018-10-04 2020-04-08 Tdeltas Ltd Compounds for new use
ES2941943T3 (es) 2019-01-17 2023-05-26 Ketolipix Therapeutics Gmbh Método para la producción de glicéridos de ácidos hidroxicarboxílicos
CN109700021A (zh) * 2019-03-04 2019-05-03 清华大学 3-羟基丁酸及其衍生物在制备预防和治疗肥胖及肥胖相关疾病的产品中的应用
CN110776425B (zh) * 2019-10-23 2021-02-26 清华大学 一种(r)-3-羟基丁酸及其低聚物的制备方法
JP7638693B2 (ja) * 2020-12-15 2025-03-04 大阪瓦斯株式会社 ヒドロキシアルカン酸結晶の製造方法及びヒドロキシアルカン酸の結晶多形体
US20240196917A1 (en) * 2021-06-01 2024-06-20 Osaka Gas Co., Ltd. Oil and fat composition containing 3-hydroxybutyric acid
WO2023283654A1 (en) * 2021-07-09 2023-01-12 Georgia State University Research Foundation, Inc. The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections
IT202100020441A1 (it) * 2021-07-30 2023-01-30 Unichem Estense S R L Miscela di un mono-estere e un di-estere, in cui detti mono-estere e di-estere sono esteri dell’acido (R)-3-idrossibutanoico con un polialcol, processo per la preparazione della miscela e relativi usi medici
CN113712140A (zh) * 2021-09-13 2021-11-30 珠海麦得发生物科技股份有限公司 一种含(r)-3羟基丁酸的固体饮料及其制备方法
AU2022381752B2 (en) * 2021-11-04 2026-01-08 Vdf Futureceuticals, Inc Ketone precursors and methods therefor
CN118591523A (zh) * 2021-11-12 2024-09-03 阿萨达股份公司 多元醇衍生的化合物
AU2022411334A1 (en) * 2021-12-14 2024-06-13 Suntory Holdings Limited Carbonated beverage, and method for enhancing sense of carbonation of beverage
CN118382365A (zh) * 2021-12-14 2024-07-23 三得利控股株式会社 含有3羟基丁酸及低级脂肪族醇的饮料及呈味改善方法
JP7223193B1 (ja) 2022-05-26 2023-02-15 大阪瓦斯株式会社 内臓脂肪低減剤およびその用途
CN116966173A (zh) * 2023-06-15 2023-10-31 浙江大学 3-羟基苯乙酸在制备改善非酒精性脂肪肝药物中的应用
CN118903420A (zh) * 2024-07-02 2024-11-08 南方医科大学 Irf4抑制剂在治疗非酒精性脂肪性肝炎的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
CN1315473C (zh) 1997-03-17 2007-05-16 英国技术集团国际有限公司 治疗组合物
EP2258742A1 (en) * 1997-12-22 2010-12-08 Metabolix, Inc. Polyhydroxyalkanoate compositons having controlled degradation rates
EP2275468A1 (en) * 2000-07-14 2011-01-19 Metabolix, Inc. Polyurethanes obtained from hydroxyalkanoates and isocyanates
EP1648952B1 (en) * 2003-06-03 2018-03-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
SE0400355D0 (sv) * 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
EP1778615A4 (en) 2004-07-20 2010-01-06 Btg Int Ltd OLIGOMERE KETONE COMPOUNDS
WO2008110034A1 (en) 2007-03-14 2008-09-18 Shantou University 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
JP5773870B2 (ja) * 2008-08-21 2015-09-02 アイシス イノヴェイション リミテッド ヒドロキシ酪酸エステル及びその医学的使用
WO2011078204A1 (ja) 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
US8865641B2 (en) * 2011-06-16 2014-10-21 The Feinstein Institute For Medical Research Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
GB201206192D0 (en) 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
GB2515603B (en) 2013-03-14 2015-10-14 Isis Innovation Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
CA2902603C (en) 2013-03-19 2021-03-02 University Of South Florida Compositions and methods for producing elevated and sustained ketosis
IN2013MU01468A (https=) * 2013-04-22 2015-04-17 Cadila Healthcare Ltd
US11814664B2 (en) * 2013-05-24 2023-11-14 Genomatica, Inc. Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate
GB201314127D0 (en) 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
US20150283163A1 (en) 2014-04-04 2015-10-08 Organic Medical Ventures, L.L.C. Muscle treatment composition and method making same
US20180008629A1 (en) 2015-01-29 2018-01-11 Yale University Compositions and Methods for Treating NLRP3 Inflammasome-Related Diseases and Disorders
EA201791982A1 (ru) * 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
CA3021784A1 (en) 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US10336812B2 (en) * 2016-05-10 2019-07-02 Janssen Biotech, Inc. GDF15 fusion proteins and uses thereof
GB201710229D0 (en) 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use

Also Published As

Publication number Publication date
US12439944B2 (en) 2025-10-14
AU2018293398A1 (en) 2020-01-16
TW201904568A (zh) 2019-02-01
JP2023120442A (ja) 2023-08-29
KR102680437B1 (ko) 2024-07-01
EP4215189A1 (en) 2023-07-26
AU2018293398B2 (en) 2023-11-23
JP7632979B2 (ja) 2025-02-19
ES2945964T3 (es) 2023-07-11
GB201810300D0 (en) 2018-08-08
JP7374000B2 (ja) 2023-11-06
EP3644982A1 (en) 2020-05-06
CA3066948A1 (en) 2019-01-03
KR20200019745A (ko) 2020-02-24
GB2567273A (en) 2019-04-10
TWI811222B (zh) 2023-08-11
CN110869012A (zh) 2020-03-06
CN110869012B (zh) 2024-06-11
DK3644982T3 (da) 2023-07-17
JP2020527547A (ja) 2020-09-10
US20200113220A1 (en) 2020-04-16
GB2567273B (en) 2020-10-07
WO2019002828A1 (en) 2019-01-03
US20260007157A1 (en) 2026-01-08
GB201710229D0 (en) 2017-08-09
EP3644982B1 (en) 2023-04-12

Similar Documents

Publication Publication Date Title
PL3644982T3 (pl) Związki 3-hydroksymaślanu do zastosowania w redukowaniu tłuszczu wątrobowego
DK3349763T3 (en) Composition for use in microbiota modulation
SG10202109655VA (en) Compositions and methods for immunooncology
SG10201606170SA (en) Estimating Vessel Intent
PT3429644T (pt) Composição compatível com a pele
ZA201704227B (en) Drawers and components for drawers
SI3496551T1 (sl) Tekoča alulozna sestava
SI3386954T1 (sl) Dimerna kontrastna sredstva
GB201507781D0 (en) Blending techniques for curve fitting
ZA201903977B (en) Pet food compositions and methods for the same
PL2839750T3 (pl) Kompozycja tłuszczowa
SG11201706046PA (en) Polishing composition
ZA201708004B (en) Ether compounds and related compositions
SG11201803364WA (en) Polishing composition
PL2956010T3 (pl) Kompozycja tłuszczów
SG11201607461PA (en) Polishing composition and polishing method using the same
GB201403969D0 (en) Compounds for use in controlling body fat
GB201609084D0 (en) System for use in bioprocessing
SG11201803362VA (en) Polishing composition
PL3245876T5 (pl) Kompozycja spożywcza do smarowania
SG11201705822VA (en) Fat composition for use in infant formula
GB201521190D0 (en) Application in german
DK3573468T3 (en) Fat Composition
PL3347444T3 (pl) Kompozycje tłuszczowe
SG11201605747PA (en) Solid fat composition and method for manufacturing the same